Microbot Medical Inc (MBOT) Director Sells $42,553.32 in Stock

Microbot Medical Inc (NASDAQ:MBOT) Director Yoseph Bornstein sold 42,132 shares of Microbot Medical stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $1.01, for a total transaction of $42,553.32. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Yoseph Bornstein also recently made the following trade(s):

  • On Tuesday, January 9th, Yoseph Bornstein sold 35,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.06, for a total transaction of $37,100.00.
  • On Wednesday, December 27th, Yoseph Bornstein sold 14,257 shares of Microbot Medical stock. The stock was sold at an average price of $1.02, for a total transaction of $14,542.14.
  • On Tuesday, December 19th, Yoseph Bornstein sold 32,067 shares of Microbot Medical stock. The shares were sold at an average price of $1.03, for a total transaction of $33,029.01.
  • On Tuesday, December 12th, Yoseph Bornstein sold 44,159 shares of Microbot Medical stock. The shares were sold at an average price of $1.04, for a total transaction of $45,925.36.
  • On Wednesday, December 6th, Yoseph Bornstein sold 15,375 shares of Microbot Medical stock. The shares were sold at an average price of $1.05, for a total transaction of $16,143.75.
  • On Tuesday, November 21st, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.21, for a total transaction of $54,450.00.
  • On Tuesday, November 28th, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.07, for a total transaction of $48,150.00.
  • On Tuesday, October 24th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.14, for a total transaction of $57,000.00.
  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.16, for a total transaction of $58,000.00.
  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.38, for a total transaction of $69,000.00.

Microbot Medical Inc (NASDAQ MBOT) traded up $0.02 during trading on Thursday, hitting $1.07. 473,800 shares of the stock traded hands, compared to its average volume of 993,300. Microbot Medical Inc has a twelve month low of $1.00 and a twelve month high of $9.94. The stock has a market cap of $41.17, a PE ratio of -1.55 and a beta of -0.41.

A hedge fund recently raised its stake in Microbot Medical stock. Vanguard Group Inc. boosted its holdings in shares of Microbot Medical Inc (NASDAQ:MBOT) by 252.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 159,992 shares of the biotechnology company’s stock after buying an additional 114,561 shares during the quarter. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 as of its most recent SEC filing. Institutional investors and hedge funds own 4.66% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Microbot Medical Inc (MBOT) Director Sells $42,553.32 in Stock” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/11/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-42132-shares-of-stock.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply